New combo therapy for myeloma shows promise but trial ends early
NCT ID NCT04855136
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 29 times
Summary
This study tested a cell therapy called bb2121 (Ide-cel) combined with other drugs in 21 adults with multiple myeloma that had returned or stopped responding to treatment. The goal was to find the safest dose and see if the combinations helped control the cancer. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 101
Jacksonville, Florida, 32224-1865, United States
-
Local Institution - 103
Nashville, Tennessee, 37203, United States
-
Local Institution - 104
Atlanta, Georgia, 30322, United States
-
Local Institution - 107
Houston, Texas, 77030, United States
-
Local Institution - 108
Boston, Massachusetts, 02117, United States
-
Local Institution - 109
Hackensack, New Jersey, 07601, United States
-
Local Institution - 110
New York, New York, 10032, United States
-
Local Institution - 111
Charlotte, North Carolina, 28204, United States
-
Local Institution - 113
San Francisco, California, 94143, United States
-
Local Institution - 114
Chicago, Illinois, 60611, United States
-
Local Institution - 117
Birmingham, Alabama, 10016, United States
-
Local Institution - 118
Philadelphia, Pennsylvania, 19107, United States
-
Local Institution - 120
Atlanta, Georgia, 30342, United States
-
Local Institution - 124
Boston, Massachusetts, 02215, United States
-
Local Institution - 201
Pamplona, 31008, Spain
-
Local Institution - 202
Salamanca, 37007, Spain
-
New York University Langone
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.